Biodesix (NASDAQ:BDSX) is focused on developing diagnostic tests intended to improve patient outcomes by answering specific ...
Individuals with chronic obstructive pulmonary disease (COPD) with coexisting obstructive sleep apnea (OSAS) have greater ...
A retrospective pooled analysis of 1,100 patients demonstrates the Nodify CDT® test’s consistent clinical performance across nodule sizes and patient populations ...
Some level of the odourless, colourless radioactive gas is in every home — but long-term overexposure is considered a Class 1 carcinogen.
Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.
Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities. Obstructive sleep apnea syndrome (OSAS), on the other hand, is usually ...
Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.
According to the American Lung Association, the national five-year lung cancer survival rate is about 29.7 percent. The ...
Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...
Affinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released a new clinical case study that ...
A pulmonologist discusses the history and influence of race-based reference equations in pulmonary function testing interpretation and patient care.
To test whether AT2‑derived lipids are required for metastasis, the researchers selectively deleted Fasn in AT2 cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results